New advances in VTE based on registry data were presented and discussed
Once again, the specialists in venous thromboembolism pertaining to the Italian group of the RIETE Registry convened their annual meeting, with the aim of presenting new advances in the disease and exchanging points of view.
On Monday, September 18th, about forty experts met in Florence to share the following advances based on data from the RIETE Registry, which now contains information from more than 72,000 patients in 24 countries:
- The use of direct-acting oral anticoagulants (DOACs) in real life confirms the findings of clinical trials.
- The treatment of pulmonary embolism varies in the countries forming part of RIETE.
- It is necessary to continue studying and analysing the ideal duration of anticoagulant treatment because there is also disparity of opinions among countries.
- Thrombosis of the abdominal veins is a serious location that is often found in patients with cancer.
After Spain, the Italian RIETE group is the most numerous and active of the registry.
5th anniversary of World Thrombosis Day
To find out how much you know about the VTE we have made a little quiz. Are you ready?
Most striking developments in WHITH 2017
Barcelona hosted the 7th International Symposium to be on Women’s Health Issues in Thrombosis and Haemostasis (WHITH), a meeting on new findings in women’s health related to VTE
New direct-acting oral anticoagulants (DOACs) can work better than classic oral anticoagulants
As indicated by one of the studies presented during the 14th Venous Thromboembolism Forum
Hospital Ramón y Cajal launches the PE Code
Hospital Ramón y Cajal of Madrid is the first Spanish centre to activate the PE Code
New advances in the relationship between cancer and thrombosis
Advances presented at the second edition of the International RIETE Meeting